canbiola, inc. (otcqb: canb) is a developer, manufacturer and seller of a variety of cannabidiol (hemp) based products such as oils, creams, moisturizers, chews,, isolate, gel caps, and concentrates. canbiola has developed its own line of proprietary products as well as seeking synergistic value through acquisitions in the cbd and the medical cannabis industry. cannabis is currently federally illegal and has legalized for medical purposes in some form in a limited number of states, but pure cbd products are legal in all 50 states. hemp cbd is the non-psychoactive component (no thc) used for treatment of pain, inflammation, and wellness programs. for more information about canbiola, inc., please visit: https://canbiola.com. additionally, canbiola’s wholly owned subsidiary pure health products, based in lacey, wa, is its prime development laboratory and production facility. canbiola’s duramed division has recently rolled out a durable medical device via its doctor network to treat pati
Company profile
Ticker
CANB
Exchange
Website
CEO
Marco Alfonsi
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
Canbiola, Inc., Wrapmail, Inc.
SEC CIK
Corporate docs
Subsidiaries
Duramed Inc. • Duramed MI, LLC • Imbibe Wellness Solutions, LLC • Pure Health Products, LLC • Pivt Labs, LLC • Green Grow Farms, Inc. • Botanical Biotech LLC ...
CANB stock data
Latest filings (excl ownership)
10-K
2023 FY
Annual report
15 Apr 24
NT 10-K
Notice of late annual filing
29 Mar 24
8-K
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
21 Mar 24
8-K
Completion of Acquisition or Disposition of Assets
20 Mar 24
8-K
Other Events
6 Mar 24
8-K
Other Events
1 Mar 24
8-K
Other Events
16 Jan 24
8-K
Other Events
26 Dec 23
8-K
Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
5 Dec 23
10-Q
2023 Q3
Quarterly report
20 Nov 23
Latest ownership filings
SC 13G/A
Arena Investors LP
14 Feb 24
SC 13G/A
Arena Investors LP
14 Feb 24
SC 13G
Clearthink Capital Partners, LLC
8 Feb 24
SC 13G/A
Arena Investors LP
14 Feb 23
SC 13G
White Hair Solutions, LLC
9 Feb 23
SC 13G
White Hair Solutions, LLC
21 Apr 22
SC 13G/A
Arena Investors LP
14 Feb 22
SC 13G/A
Arena Investors LP
16 Feb 21
SC 13G
Arena Investors LP
30 Dec 20
SC 13G
Accutus Consulting Group, Inc.
15 Oct 20
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 31.32 k | 31.32 k | 31.32 k | 31.32 k | 31.32 k | 31.32 k |
Cash burn (monthly) | 30.71 k | 262.75 | 1.39 mm | 901.70 k | 68.88 k | 165.20 k |
Cash used (since last report) | 212.04 k | 1.81 k | 9.59 mm | 6.23 mm | 475.57 k | 1.14 mm |
Cash remaining | -180.72 k | 29.50 k | -9.56 mm | -6.19 mm | -444.25 k | -1.11 mm |
Runway (months of cash) | -5.9 | 112.3 | -6.9 | -6.9 | -6.5 | -6.7 |
Institutional ownership, Q1 2023
8.1% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 1 |
Opened positions | 0 |
Closed positions | 1 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 1.82 mm |
Total shares | 3.64 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
White Hair Solutions | 3.64 mm | $1.82 mm |